To conclude, this work highlighted that downregulation of KRT80 impedes proliferative, invasive capabilities, and EMT of NSCLC cells, possibly via adjusting the TGF-β/SMAD pathway. Here, KRT80 is linked to non-small cell lung carcinoma.